evicanumab

Regeneron's Praluent sidekick nabs speedy FDA review, with February PDUFA date
Fierce Biotech
Wed, 08/12/20 - 10:53 am
Regeneron
evicanumab
FDA
Homozygous Familial Hypercholesterolemia